Skip to main content

What the FDA labels say about taking them together

Droxidopa and midodrine

Droxidopa's FDA label of July 1, 2019 names midodrine in its drug interactions section, and midodrine's label names droxidopa too. The midodrine label: “The risk of hypertension increases with concomitant administration of drugs that increase blood pressure.”

Check it at the source: the droxidopa FDA label on DailyMed (effective July 1, 2019, Lundbeck Pharmaceuticals LLC); the midodrine FDA label on DailyMed (effective December 4, 2025, Novugen Pharma (USA) LLC).

What does the droxidopa label say about midodrine?

Droxidopa label, drug interactions

Drugs that Increase Blood Pressure Administering NORTHERA in combination with other agents that increase blood pressure (e.g., norepinephrine, ephedrine, midodrine, and triptans) would be expected to increase the risk for supine hypertension.

Source: FDA drug label (Northera), Lundbeck Pharmaceuticals LLC, effective July 1, 2019 (SPL set 2179f02c-48d7-48eb-8007-5ae43d8d16bc), via openFDA; the full label on DailyMed

What does the midodrine label say about droxidopa?

Midodrine label, drug interactions

The risk of hypertension increases with concomitant administration of drugs that increase blood pressure (phenylephrine, pseudoephedrine, ephedrine, dihydroergotamine, thyroid hormones, or droxidopa).

Source: FDA drug label (Midodrine Hydrochloride), Novugen Pharma (USA) LLC, effective December 4, 2025 (SPL set 2bf011fe-d114-42a4-93e2-76a993a3ba34), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

14Droxidopa generic labelers
33Midodrine generic labelers
DroxidopaMidodrine
Labeled forn/an/a
Boxed warningYesYes
Pharmacy cost (NADAC)$0.472 per capsule 100 mg capsule$0.111 per tablet 5 mg tablet
Shortage nowNo current entryNo current entry

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?